GARCHING, Germany & HOUSTON--(BUSINESS WIRE)--ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and RadioMedix Inc., a clinical stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback